Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,992 public trials 1,210 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations: AdventHealth Orlando, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Recruiting

A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma

NCT07710690

Conditions: Glioma, HGG, High Grade Glioma, +8 more
Locations: Huashan Hospital Affiliated with Fudan University Shanghai, China

Zhongnan Hospital of Wuhan University Wuhan, China

The Second Affiliated Hospital of Air Force Medical University Xi'an, China

View Trial Details

Recruiting

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

Conditions: Bone Cancer, NOS, Bone Diseases, Bone Neoplasms, +67 more
Locations: Fairbanks Memorial Hospital Fairbanks, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Cancer Center at Saint Joseph's Phoenix, Arizona, United States

Mercy Hospital Fort Smith Fort Smith, Arkansas, United States

View all 347 locations

View Trial Details

Recruiting

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

NCT07225621

Conditions: Astrocytoma, GBM, Glioblastoma, +8 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Albany Medical Center Albany, New York, United States

Dent Neurologic Institute Buffalo, New York, United States

View Trial Details

Recruiting

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

NCT03892993

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma

NCT06850766

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +9 more
Locations: London Health Sciences Centre London, Ontario, Canada

The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada

View Trial Details

Recruiting

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

NCT04623931

Conditions: Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT00001823

Conditions: Bladder Cancer, Colonic Diseases, Colorectal Cancer, +36 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions: Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations: Precision NextGen Oncology Beverly Hills, California, United States

OPN Healthcare, Inc Glendale, California, United States

University of Southern California Los Angeles, California, United States

MDR Core Network Boynton Beach, Florida, United States

View Trial Details

Recruiting

Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

NCT05704647

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions